Pfizergate

Two recent controversies – Pfizergate and Piepergate – have thrown a wrench into Ursula von der Leyen’s re-election bid for the European Commission presidency. What impacts will they have and who will benefit form them? Žiga Faktor, head of EUROPEUM´s Institute Brussels office, comments in an article for The Parliament Magazine.

Recent investigation into the purchase of Pfizer vaccines by the EU has revealed the involvement of Ursula von der Leyen, President of the European Commission, raising questions about transparency and accountability. With the interconnection of several cases, including allegations of undisclosed agreements and legal actions, attention to negotiation processes and financial management within the Commission is increasing. The outcomes of these investigations may influence public trust and future leadership of the EU, highlighting the delicate balance between transparency and privacy protection. Žiga Faktor, Deputy Director and Head of the Brussels Office of the EUROPEUM Institute, offered a commentary for iRozhlas.cz.